Compare ATO & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATO | IQV |
|---|---|---|
| Founded | 1906 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Oil/Gas Transmission | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.0B | 28.6B |
| IPO Year | 1994 | 2013 |
| Metric | ATO | IQV |
|---|---|---|
| Price | $186.17 | $175.99 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 16 |
| Target Price | $177.14 | ★ $227.13 |
| AVG Volume (30 Days) | 642.2K | ★ 1.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.14% | N/A |
| EPS Growth | ★ 9.22 | 4.67 |
| EPS | 2.44 | ★ 7.84 |
| Revenue | $4,702,755,000.00 | ★ $9,739,000,000.00 |
| Revenue This Year | $15.32 | $6.77 |
| Revenue Next Year | $10.09 | $5.89 |
| P/E Ratio | $76.30 | ★ $22.55 |
| Revenue Growth | 12.91 | ★ 41.60 |
| 52 Week Low | $149.98 | $134.65 |
| 52 Week High | $192.51 | $247.05 |
| Indicator | ATO | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 50.45 | 54.48 |
| Support Level | $183.06 | $159.42 |
| Resistance Level | $189.06 | $193.26 |
| Average True Range (ATR) | 2.96 | 6.00 |
| MACD | -0.43 | 1.33 |
| Stochastic Oscillator | 36.26 | 74.66 |
Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3.3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.